Advanced Enzyme Technologies Ltd.

View in App
389.55 +3.25 ▲0.8%

26 April 2024, 11:21:18 AM
Volume: 45,462

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.advancedenzymes.com
Market Cap 4,309.70 Cr.
Enterprise Value(EV) 4,204.37 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 12.26 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 31.43 Trailing Twelve Months Ending 2023-12
Industry PE 41.74 Trailing Twelve Months Ending 2023-12
Book Value / Share 115.43 Trailing Twelve Months Ending 2023-12
Price to Book Value 3.34 Calculated using Price: 385.40
Dividend Yield 1.30 Period Ending 2023-03
No. of Shares Subscribed 11.18 Cr. 111,824,075 Shares
FaceValue 2
About Advanced Enzyme Technologies Ltd.
The company is a fully integrated enzyme manufacturing company driven by extensive focus on research and development (R&D) of various enzymes, enzyme blends, enzyme products and customized enzyme solutions. Its experienced and qualified R&D team strives to develop creative, cost-effective unique and innovative solutions, thereby enabling their customers to develop superior products and processes. The company products assist its customers in making most of their resources, optimizing their processes, improving their product quality, saving their time and money while also mitigating the impact on the environment. It supplies these value-added and eco-safe enzyme products to diverse end-user industries like human healthcare and nutrition, animal nutrition, food processing, baking, dairy and cheese processing, fruit and vegetable processing, cereal extraction, brewing, grain processing, protein processing, oil and fat processing, biomass processing, textile processing, leather processing, paper & pulp processing, bio-fuels, bio-catalysis etc. Although, the company has the capability to manufacture enzymes using all the four natural origins viz. plant, animal, bacterial and fungal, their major focus is on developing enzymes through microbial fermentation.

Advanced Enzyme Technologies Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Advanced Enzyme Technologies Ltd. Performance

View details >>
1 Day
+0.84%
1 Week
+8.12%
1 Month
+8.81%
3 Month
+4.65%
6 Month
+27.99%
1 Year
+52.05%
2 Year
+28.52%
5 Year
+103.69%
10 Year

Advanced Enzyme Technologies Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 27.31 31.32 25.06 18.34 18.82 17.61 16.77 12.04 8.94
Return on Capital Employed (%) 25.49 35.68 31.53 25.88 24.96 23.21 22.93 16.66 12.26
Return on Assets (%) 12.81 17.81 18 14.28 15.13 14.98 14.27 10.28 7.78

Advanced Enzyme Technologies Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 212 278 464 559 679 840 971 1,089 1,235 1,248
Non Curr. Liab. 64 56 32 43 30 39 49 59 49 46
Curr. Liab. 131 111 62 99 65 60 68 60 78 87
Minority Int. 4 5 21 23 26 28 62 52 49 50
Equity & Liab. 412 450 583 727 805 971 1,149 1,260 1,411 1,433
Non Curr. Assets 307 311 440 512 518 591 633 656 688 696
Curr. Assets 104 140 138 211 282 376 516 604 722 737
Misc. Exp. not W/O
Total Assets 412 450 583 727 805 971 1,149 1,260 1,411 1,433

Advanced Enzyme Technologies Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 223 294 329 391 420 444 502 529 541 605
Other Income 3 1 3 3 6 6 9 6 25 38
Total Income 226 295 332 394 425 450 511 536 566 643
Total Expenditure -133 -156 -178 -227 -237 -241 -269 -327 -383 -412
PBIDT 93 139 154 166 188 209 241 209 183 231
Interest -9 -8 -4 -9 -5 -4 -3 -3 -3 -3
Depreciation -9 -9 -13 -18 -21 -26 -29 -35 -35 -34
Taxation -23 -41 -44 -45 -46 -46 -59 -47 -37 -51
Exceptional Items -4 -4 -4
PAT 52 77 93 94 116 133 151 124 104 139
Minority Interest -1 -1 -1 -3 -5 -4 -5 -4 2 -2
Share Associate
Other Related Items
Consolidated Net Profit 51 76 92 90 111 129 146 120 106 137
Adjusted EPS 5 7 8 8 10 12 13 11 9 12

Advanced Enzyme Technologies Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 56 54 93 107 116 129 141 163 122 140
Cash Fr. Inv. -9 -11 -5 -60 -78 -125 -45 -26 -4 -298
Cash Fr. Finan. -33 -36 -63 -65 -2 -43 -39 -26 -49 -26
Net Change 13 6 26 -18 36 -39 58 111 70 -184
Cash & Cash Eqvt 2 4 25 8 61 23 83 192 267 96

Advanced Enzyme Technologies Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 52.70 52.70 49.87 49.87 49.87 46.52 45.92 43.62 43.49
Public 47.30 47.30 50.13 50.13 50.13 53.48 54.08 56.38 56.51
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Advanced Enzyme Technologies Ltd. Announcements

View details >>
Tue, 09 Apr 2024
Disclosure under SEBI Takeover Regulations
Advanced Enzyme Technologies Limitedￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠ
Mon, 08 Apr 2024
Disclosure under SEBI Takeover Regulations
Chandrakumar Laxminarayan rathiￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠ
Mon, 08 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Advanced Enzyme Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Advanced Enzyme Technologies Ltd. Technical Scans

View details >>
Thu, 25 Apr 2024
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months

Advanced Enzyme Technologies Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,507.50 -0.8%
Cipla Ltd. 113,471.29 1,407.50 +0.1%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,243.30 +0.4%
Divi's Laboratories Ltd. 101,959.84 3,963.50 +3.1%
Zydus Lifesciences Ltd. 95,944.41 945.80 -0.6%
Mankind Pharma Ltd. 95,926.91 2,418.00 +0.8%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,318.00 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,507.50 -0.8%
Cipla Ltd. Consolidated 2023-12 30.60 1,407.50 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,243.30 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,963.50 +3.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 945.80 -0.6%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,418.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,318.00 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,507.50 -0.8%
Cipla Ltd. Consolidated 2023-12 4.38 1,407.50 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,243.30 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,963.50 +3.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 945.80 -0.6%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,418.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,318.00 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,507.50 -0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,407.50 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,243.30 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,963.50 +3.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 945.80 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,418.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,318.00 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,507.50 -0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,407.50 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,243.30 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,963.50 +3.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 945.80 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,418.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,318.00 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,507.50 -0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,407.50 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,243.30 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,963.50 +3.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 945.80 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,418.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,318.00 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,507.50 -0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,407.50 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,243.30 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,963.50 +3.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 945.80 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,418.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,318.00 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,507.50 -0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,407.50 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,243.30 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,963.50 +3.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 945.80 -0.6%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,418.00 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,318.00 -1.0%

Advanced Enzyme Technologies Ltd. FAQ's

What is Advanced Enzyme share price?
Can I buy Advanced Enzyme shares now?
What is the Dividend Yield of Advanced Enzyme?
What is the Market Cap of Advanced Enzyme?
What are the key metrics to analyse Advanced Enzyme?
What is the 52 Week High and Low of Advanced Enzyme?
What is the trend of Advanced Enzyme share price?